This stock is interesting some investors as a ‘buy’ prospect as a recovery play.
Our current analysis says Not! Not yet anyway. Our analysis shows this stock as an ‘avoid’ and not as a ‘buy’ in view of its current decline. The risk involved in buying now is too great as there has been no signal yet that its downturn has finished.
The following points are relevant -
1. The stock’s dominant trend – as shown by the, now falling, 30wk MA on the weekly chart and the negative crossover of the two exponential MAs on the daily chart – is now the Downtrend so, to buy now would run counter to the dominant trend and thereby involve extra risk as the dominant trend may well yet take the price lower.
2. The price has fallen below the 158p support level of the 25% retracement of the stock’s previous strong Uptrend (from the Oct’08 low at 22p to the Nov’10 high at 203p) and is falling towards the next level of potential support of the 50% retracement level at 112p.
3. Although the volume/spread analysis suggests that the worst of the selling may be over there is, as yet, no firm indication that buyers are returning to the stock (and without active buying the price is not going to rise to any appreciable extent).
Weekly -

Daily -

(Click on the charts to enlarge them).
Conclusion -
The stock must stay above the 112p level in order to have any possibility of a recovery rally. (To fall below 112p would indicate the potential for a possible decline all the way down to the 67p level).
Even then, should a rally commence from above 112p, we must wait for the dominant trend to change back to an Uptrend ( to be indicated by a positive crossover of the two exponential MAs on the daily chart) as, otherwise, it will likely be just a minor reaction within the main Downtrend – which will quickly reassert itself.
Before the trend changes back to Uptrend the price is likely to pull itself back up towards the 158p level which, then, will be considered as likely to produce resistance to further increase. So, not until the 158p level has been broken to the upside should we consider this the risk element to be sufficiently reduced as to present the stock as worthy of purchase.
160p is then a suitable price to consider Centamin Egypt as a buy – based on the current situation. Much can change between now and then and re-analysis later may create a different conclusion.
A.G.Saunders Chief Analyst, ShareHunter.com 7th March 2011
Recent Comments